Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Intangibles (2016 - 2025)

Mimedx (MDXG) has disclosed Intangibles for 15 consecutive years, with $14.2 million as the latest value for Q4 2025.

  • Quarterly Intangibles rose 21.78% to $14.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.2 million through Dec 2025, up 21.78% year-over-year, with the annual reading at $14.2 million for FY2025, 21.78% up from the prior year.
  • Intangibles hit $14.2 million in Q4 2025 for Mimedx, up from $11.1 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $14.2 million in Q4 2025 to a low of $5.0 million in Q3 2022.
  • Historically, Intangibles has averaged $8.1 million across 5 years, with a median of $5.8 million in 2021.
  • Biggest five-year swings in Intangibles: fell 22.15% in 2021 and later skyrocketed 121.15% in 2024.
  • Year by year, Intangibles stood at $5.4 million in 2021, then grew by 8.71% to $5.9 million in 2022, then decreased by 10.17% to $5.3 million in 2023, then soared by 121.15% to $11.6 million in 2024, then grew by 21.78% to $14.2 million in 2025.
  • Business Quant data shows Intangibles for MDXG at $14.2 million in Q4 2025, $11.1 million in Q3 2025, and $12.0 million in Q2 2025.